Monopar Therapeutics MNPR
NASDAQ MNPR
$74.23 +2.76 (+3.86%)
At close: Oct 20, 2026 · 4:00 PM EDT

Monopar Therapeutics (MNPR) Total Debt (2020)

Updated

Monopar Therapeutics (MNPR) posted Total Debt of $122,400 for Q3 2020, unchanged from the prior quarter.

Analysis

Monopar Therapeutics (MNPR) Total Debt (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 54.91 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 49.04 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 70.82 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn 53.91 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 9.59 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 32.35 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 57.30 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 26.25 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 63.19 Bn
10 Monopar Therapeutics 635.73 Mn 353.96 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 122,400.00
Jun 30, 2020 122,400.00
API Access

Monopar Therapeutics Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=MNPR&period=max&api_key=YOUR_API_KEY